The first series of cases of ketosis-prone type 2 diabetes (flatbush diabetes) in Brazilian adults

• Published in: Archives of Endocrinology and Metabolism Vol. 65; no. 2; pp. 231 - 236
• Main Authors: de Lima Ramaldes, Luana Aparecida, Dos Santos, Sarah Simaan, de Sa, João Roberto, Dualib, Patrícia Médici, Dib, Sérgio Atala
• Format: Journal Article
• Language: English
• Published: Brazil Sociedade Brasileira de Endocrinologia e Metabologia 01.11.2021; Brazilian Society of Endocrinology and Metabolism
• Subjects: Adult; Brazil; Case Report; Diabetes Mellitus, Type 2 - drug therapy; Diabetic Ketoacidosis; Female; Humans; Insulin; Ketosis; Male; Retrospective Studies; Brazil
• ISSN: 2359-3997; 2359-4292
• DOI: 10.20945/2359-3997000000329

Ketosis-prone type 2 diabetes (KPD) is an emerging form of diabetes mellitus characterized by unprovoked ketoacidosis, absence of autoimmunity and beta-cell dysfunction. The KPD may improve after initial glycemic compensation and evolve to exogenous insulin independence, most cases were observed in populations with African or Hispanic backgrounds. We reviewed the literature on KPD and, to date, only one case of KPD has been described in Brazil's multi-ethnic population. A group of adult Brazilian KPD patients without autoimmunity and insulinopenia was identified for this study. We report a retrospective study of four KPD cases (3 males) evaluated in southeast Brazil, the patients were overweight or obese, age between the third and fifth decades of life, had a family history of type 2 diabetes, hyperglycemia (809.5 ± 344.2 mg/dL), acidosis (pH 7.21 ± 0.07; normal range (nr): 7.35-7.45 and bicarbonate 9.1 ± 6.2; nr: 22-26 mEq/mL), ketonuria (142.5 ± 114.4 mg/dL; nr: absence), absence of glutamic acid decarboxylase antibodies (GAD-65), and beta-cell function reserve (C-peptide 1.19 ± 0.53 ng/mL - nr: 1.1-4.4 ng/mL) on diagnosis. After glycemic compensation, there was increase of C-peptide (2.21 ± 0.41) indicating the recovery of beta-cell function and the time to insulin independence was 7.7 ± 3.5 months. They evolved after the period of glucotoxicity with insulin withdrawal and could be treated with oral antidiabetic therapy. This is the first case series of KPD described in Brazil being characterized by ketoacidosis at diagnosis, absence of autoimmunity, recovery of beta-cell function and insulin independence.